As the Endocrine Society prepares to welcome the endocrinology world from around the world to Boston from ENDO 2024, Endocrine News is once again highlighting our host city’s local flair, as well as some conference highlights as well. Plus, we’ve got recommendations from some of your in-the-know colleagues as well! Boston may be one of...
The Endocrine Society has appointed Zane B. Andrews, PhD, of Monash University in Melbourne, Australia, as editor-in-chief of its flagship basic science journal, Endocrinology. Andrews has been deputy editor of the journal since 2020 and will be taking on this role as previous editor-in-chief Carol Lange, PhD, of the University of Minnesota in Minneapolis, Minn.,...
These steps are in line with Endocrine Society recommendations. On April 10, the Biden-Harris Administration issued the first-ever national, legally enforceable drinking water standard to protect communities from exposure to harmful per-and polyfluoroalkyl substances (PFAS), also known as ‘forever chemicals.’ As part of the administration’s commitment to combatting PFAS, the Environmental Protection Agency (EPA) announced...
Three editors of the Journal of the Endocrine Society (JES) recently published an editorial titled “From Fundamentals to the Clinic: Advancing Obesity Research in Endocrinology,” recognizing that the landscape of obesity research has rapidly evolved in the past five years, and that sharing scientific data is an important step toward addressing the growing global obesity...
On April 13, the Endocrine Society and the Korean Endocrine Society (KES) officially entered into a memorandum of Understanding (MOU) during the 12th Seoul International Congress of Endocrinology and Metabolism (SICEM) in conjunction with the 43rd Annual Scientific Meeting of the KES, which took place in Seoul, South Korea, April 11 – 13, 2024. This...
TIME Magazine recently recognized three Endocrine Society members in its 100 Most Influential People of 2024: Daniel J. Drucker, MD, professor of medicine, University of Toronto, Toronto, Canada, editor-in-chief, Endocrine Reviews; Joel F. Habener, MA, MD, chief of Laboratory of Molecular Endocrinology, Massachusetts General Hospital; and Svetlana Mojsov, PhD, research associate professor at Rockefeller University in...
Like it or not, artificial intelligence (AI) is here to stay, and its impact on both the science and practice of endocrinology will soon be quite evident. The ENDO 2024 Plenary session, “Artificial Intelligence in Health and Biomedical Research: The Future Is Now,” will no doubt answer many questions on the minds of endocrinologists in...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Clinical Trial Interim Data Show Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome On April 11, Amylyx Pharmaceuticals announced interim data from the ongoing Phase 2 HELIOS clinical trial of AMX0035 (sodium phenylbutyrate [PB] and...
The Endocrine Society has appointed Zane B. Andrews, PhD, of Monash University in Melbourne, Australia, as editor-in-chief of its flagship basic science journal, Endocrinology. Andrews has been deputy editor of the journal since 2020 and will be taking on this role as previous editor-in-chief Carol Lange, PhD, of the University of Minnesota in Minneapolis, Minn.,...
Three editors of the Journal of the Endocrine Society (JES) recently published an editorial titled “From Fundamentals to the Clinic: Advancing Obesity Research in Endocrinology,” recognizing that the landscape of obesity research has rapidly evolved in the past five years, and that sharing scientific data is an important step toward addressing the growing global obesity...
